Novavax, Inc. (NVAX)

Last Closing Price: 14.40 (2024-05-16)

Net Income (Annual)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Novavax, Inc. (NVAX) had Net Income of $-545.06M for the most recently reported fiscal year, ending 2023-12-31.

Figures for fiscal year ending 2023-12-31
Income Statement Financials
$983.71M
Net Income
$-545.06M
$343.77M
$639.94M
$1.55B
$-566.51M
$23.48M
$-543.03M
$-543.03M
$-545.06M
$-545.06M
$-545.06M
$-545.06M
$-566.51M
$-525.29M
100.77M
100.77M
$-5.41
$-5.41
Balance Sheet Financials
$1.14B
$305.77M
$653.60M
$1.80B
$1.64B
$223.94M
$879.28M
$2.51B
$-716.93M
$-844.38M
$-716.93M
139.51M
Cash Flow Statement Financials
$-713.97M
$-58.81M
$4.47M
$1.35B
$583.81M
$-765.03M
$85.36M
--
--
Fundamental Metrics & Ratios
0.70
--
--
-0.45
-0.32
65.05%
-57.59%
-57.59%
-53.40%
-55.20%
-55.41%
$-767.74M
--
--
--
0.55
8.24
3.31
110.29
76.03%
64.55%
-30.32%
110.56%
$-5.14
$-7.62
$-7.09